Previous Statements by MDVN
» Medivation CEO Discusses Q3 2010 Results - Earnings Call Transcript
» Medivation, Inc. Q2 2010 Earnings Call Transcript
» Medivation, Inc. Q1 2010 Earnings Call Transcript
OncoMed Pharmaceuticals, Geron and Akorn were among the biotech stock movers in premarket trading on Monday.
David Hung will become Axovant's CEO after completing the $14 billion sale of Medivation to Pfizer.